Nina Shah | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma (journal article) Reyes, Kevin R. \| Liu, Yen-Chun \| Huang, Chiung-Yu \| Banerjee, Rahul \| Martin, Thomas \| Wong, Sandy W. \| Wolf, Jeffrey L. \| Arora, Shagun \| Shah, Nina \| Chari, Ajai \| Chung, Alfred Blood Advances, volume 8, issue 9, pages 2207-2216 (2024). 10.1182/bloodadvances.2023012066 Cited by (4) \| Cite \| Source
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy (journal article) Ledergor, Guy \| Fan, Zenghua \| Wu, Kai \| McCarthy, Elizabeth \| Hyrenius-Wittsten, Axel \| Starzinski, Alec \| Chang, Hewitt \| Bridge, Mark \| Kwek, Serena S \| Cheung, Alexander \| ... \| Fong, Lawrence Blood Advances (2024). 10.1182/bloodadvances.2023012416 Cited by (2) \| Cite \| Source
Randomized phase 2 study of digital life coaching during transplantation for myeloma (journal article) Banerjee, Rahul \| Huang, Chiung-Yu \| Ryan, Chloe \| Lee, Albert \| Brassil, Kelly J. \| Moore, Jasmine \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy W. \| Wolf, Jeffrey \| ... \| Shah, Nina Bone Marrow Transplantation, volume 58, issue 12, pages 1406-1409 (2023). 10.1038/s41409-023-02091-4 Cited by (1) \| Cite \| Source
Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma (journal article) Duvalyan, Eva \| Shah, Nina \| Lo, Mimi \| Martin, Thomas \| Wolf, Jeffrey L. \| Chung, Alfred \| Arora, Shagun \| Huang, Chiung-Yu \| Wong, Sandy W. Leukemia & Lymphoma, volume 64, issue 11, pages 1888-1891 (2023). 10.1080/10428194.2023.2240920 Cited by (4) \| Cite \| Source
P-453 Randomized phase II study of digital life coaching during stem cell transplantation for myeloma (journal article) Banerjee, Rahul \| Huang, Chiung-Yu \| Ryan, Chloe \| Lee, Albert \| Brassil, Kelly \| Moore, Jasmine \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy \| Wolf, Jeffrey \| ... \| Shah, Nina Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). 10.1016/S2152-2650(23)02070-0 Cite \| Source
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma (journal article) Zafar, Aneeqa \| Huang, Chiung-Yu \| Lo, Mimi \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy W. \| Wolf, Jeffrey \| Martin, Thomas G. \| Shah, Nina \| Banerjee, Rahul Transplantation and Cellular Therapy, volume 29, issue 8, pages 504.e1-504.e7 (2023). 10.1016/j.jtct.2023.05.016 Cited by (6) \| Cite \| Source
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies (journal article) Tsang, Mazie \| Bischoff, Kara \| Schoenbeck, Kelly L. \| Berry, Kim \| O’Riordan, David \| Fakhri, Bita \| Wong, Sandy W. \| Shah, Nina \| Olin, Rebecca \| Andreadis, Charalambos \| ... \| Rabow, Michael Blood Advances, volume 7, issue 13, pages 3146-3149 (2023). 10.1182/bloodadvances.2022009039 Cited by (1) \| Cite \| Source
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single‐centre retrospective study (journal article) Ge, Alex Y. \| Huang, Chiung‐Yu \| Banerjee, Rahul \| Knoche, Jennifer \| Chung, Alfred \| Arora, Shagun \| Martin, Thomas G. \| Wolf, Jeffrey \| Wong, Sandy W. \| Wiita, Arun P. \| Shah, Nina British Journal of Haematology, volume 201, issue 5, pages 935-939 (2023). 10.1111/bjh.18711 Cited by (1) \| Cite \| Source
Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trial (journal article) Delforge, Michel \| Otero, Paula Rodríguez \| Shah, Nina \| Moshkovich, Olga \| Braverman, Julia \| Dhanda, Devender S. \| Lanar, Sally \| Devlen, Jennifer \| Miera, Matthew \| Gerould, Heather \| ... \| Munshi, Nikhil C. Leukemia Research, volume 129 (2023). 10.1016/j.leukres.2023.107074 Cited by (6) \| Cite \| Source
Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma (journal article) Reyes, Kevin R. \| Huang, Chiung-Yu \| Lo, Mimi \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy W. \| Wolf, Jeffrey \| Olin, Rebecca L. \| Martin, Thomas \| Shah, Nina \| Banerjee, Rahul Transplantation and Cellular Therapy, volume 29, issue 6, pages 350-355 (2023). 10.1016/j.jtct.2023.03.012 Cited by (14) \| Cite \| Source
Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis (journal article) Kennedy, Vanessa E. \| Natsuhara, Kelsey \| Maringanti, Sireesha A. \| Shah, Nina D. \| Arora, Shagun \| Wolf, Jeffrey \| Martin, Thomas G. \| Aras, Mandar A. \| Chung, Alfred \| Wong, Sandy W. Current Problems in Cancer, volume 47, issue 3, pages 100953- (2023). 10.1016/j.currproblcancer.2023.100953 Cited by (3) \| Cite \| Source
Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma (journal article) Natsuhara, Kelsey H. \| Huang, Chiung-Yu \| Knoche, Jennifer \| Arora, Shagun \| Chung, Alfred \| Martin, Thomas \| Wolf, Jeffrey \| Wong, Sandy W. \| Shah, Nina \| Banerjee, Rahul Leukemia & Lymphoma, volume 64, issue 6, pages 1186-1193 (2023). 10.1080/10428194.2023.2201365 Cited by (1) \| Cite \| Source
Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology (journal article) Shah, Nina \| Mustafa, S. Shahzad \| Vinh, Donald C. Critical Reviews in Oncology/Hematology, volume 181 (2023). 10.1016/j.critrevonc.2022.103896 Cited by (6) \| Cite \| Source
Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access (journal article) Mikhael, Joseph \| Fowler, Jessica \| Shah, Nina JCO Oncology Practice, volume 18, issue 12, pages 800-807 (2022). 10.1200/OP.22.00315 Cited by (35) \| Cite \| Source
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States (journal article) Jagannath, Sundar \| Joseph, Nedra \| He, Jinghua \| Crivera, Concetta \| Fu, Alex Z. \| Garrett, Ashraf \| Shah, Nina Oncology and Therapy, volume 10, issue 2, pages 411-420 (2022). 10.1007/s40487-022-00198-0 Cited by (2) \| Cite \| Source
Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy (journal article) Reyes, Kevin R \| Liu, Yen-Chun \| Huang, Chiung-Yu \| Banerjee, Rahul \| Martin, Thomas \| Shah, Nina \| Wong, Sandy W. \| Wolf, Jeffrey L. \| Arora, Shagun \| Chung, Alfred Blood, volume 140, issue Supplement 1, pages 617-619 (2022). 10.1182/blood-2022-160401 Cited by (7) \| Cite \| Source
Phase II Study of Pembrolizumab in Multiple Myeloma Patients Relapsing after or Refractory to Anti-BCMA CAR-T Therapies (journal article) Chung, Alfred \| Huang, Chiung-Yu \| Martin, Thomas \| Wolf, Jeffrey L. \| Wong, Sandy W. \| Shah, Nina Blood, volume 140, issue Supplement 1, pages 12651-12652 (2022). 10.1182/blood-2022-170744 Cited by (2) \| Cite \| Source
Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma (journal article) Reyes, Kevin R. \| Huang, Chiung-Yu \| Lo, Mimi \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy W. \| Wolf, Jeffrey L. \| Martin, Thomas \| Shah, Nina \| Banerjee, Rahul Blood, volume 140, issue Supplement 1, pages 5105-5107 (2022). 10.1182/blood-2022-160362 Cited by (3) \| Cite \| Source
Intensity of Cyclophosphamide-Based Bridging Regimens before BCMA-Directed CAR-T Therapy (journal article) Zafar, Aneeqa A \| Huang, Chiung-Yu \| Lo, Mimi \| Knoche, Jen \| Arora, Shagun \| Chung, Alfred \| Wong, Sandy W. \| Wolf, Jeffrey L. \| Martin, Thomas \| Shah, Nina \| Banerjee, Rahul Blood, volume 140, issue Supplement 1, pages 5218-5220 (2022). 10.1182/blood-2022-162122 Cite \| Source
Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Who Are Triple-Class Exposed to an Immunomodulatory Agent, a Proteasome Inhibitor, and an Anti-CD38 Antibody (journal article) Shah, Nina \| Vij, Ravi \| Roberts, Jenna S. \| Rajkovic, Ivana \| Silbermann, Rebecca \| Hillengass, Jens \| Dhanasiri, Sujith \| Braverman, Julia \| McMillan, Abigail \| Dhanda, Devender Blood, volume 140, issue Supplement 1, pages 13259-13261 (2022). 10.1182/blood-2022-158235 Cite \| Source